ELCO Management
SLS icon

ELCO Management’s SELLAS Life Sciences SLS Stock Holding History

ELCO Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$301K Buy
24,418
+10,209
+72% +$128K 0.14% 125
2026
Q2 		$210K Sell
14,209
-400
-3% -$2.76K 0.09% 167
2026
Q1 		$61.8K Hold
14,609
– – 0.03% 168
2025
Q4 		$55.1K Buy
14,609
+600
+4% +$1.17K 0.03% 155
2025
Q3 		$22.6K Buy
+14,009
New +$25K 0.01% 164

Other funds holding SLS

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

ELCO Management's SLS Position: Q3 2026 in Review

ELCO Management increased its SELLAS Life Sciences (SLS) stake by 72% in Q3 2026, buying an estimated $128K and bringing the position to 24,418 shares worth $301K. The position accounts for 0.14% of the portfolio, ranked #125.

ELCO Management first reported a position in SLS in Q3 2025 and has held it in 5 quarters since. 140 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • ELCO Management held 24,418 shares of SELLAS Life Sciences worth $301K as of Q3 2026.
  • ELCO Management bought 10,209 SELLAS Life Sciences shares in Q3 2026, an estimated $128K.
  • SELLAS Life Sciences made up 0.14% of ELCO Management's portfolio in Q3 2026, its #125 holding.
  • ELCO Management first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 5 quarters since.
  • 140 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on ELCO Management's 13F filing for Q3 2026, filed 14 Oct 2026.